Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-13T00:46:32.017Z Has data issue: false hasContentIssue false
  • English
  • Français

The local antibody response to R.S. virus infection in the respiratory tract

Published online by Cambridge University Press:  15 May 2009

R. Scott  and
P. S. Gardner
R. Scott
Affiliation:
Department of Virology, Royal Victoria Infirmary, and University of Newcastle upon Tyne, Newcastle upon Tyne 1
P. S. Gardner
Affiliation:
Department of Virology, Royal Victoria Infirmary, and University of Newcastle upon Tyne, Newcastle upon Tyne 1
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Nasopharyngeal secretions were taken during the acute phase of illness from 66 infants and children admitted to hospital with lower respiratory tract infections. Second secretions were taken, after an interval of 7 days, from 33 of these patients. A significant increase in neutralizing activity to R.S. virus was demonstrated in the nasopharyngeal secretions of patients in response to severe R.S. virus infection. Seventeen out of 25 patients (68%) with R.S. virus infections developed a rise in secretory neutralizing titre, compared with only 1 out of 8 patients (13%) with respiratory infections not involving R.S. virus.

A high titre of secretory neutralizing activity was found more often in the acute phase of illness in patients with R.S. virus infections, especially bronchiolitis, than in patients with respiratory infections not involving R.S. virus. Fifteen out of 34 patients (44%) with R.S. virus bronchiolitis were found to possess a neutralizing titre of 1/4 or more in their first secretions, compared with 4 out of 12 patients (33%) with R.S. virus infections other than bronchiolitis and 3 out of 20 patients (15%) with respiratory infections not involving R.S. virus.

A quantitative analysis of the immunoglobulins present in the secretions indicated that IgA was the only immunoglobulin consistently present at a detectable concentration. The geometric mean values of IgA, IgM and IgG in the secretions examined were found to be 22·3, 4·3 and 5·3 mg./lOO ml. respectively.

The neutralizing activity against R.S. virus, present in the secretions, was shown to be due to specific IgA antibody. This was accomplished by removing the neutralizing activitv in two secretions bv absorotion with anti-IaA serum.

Type
Research Article
Information
Journal of Hygiene , Volume 72 , Issue 1 , February 1974 , pp. 111 - 120
Copyright
Copyright © Cambridge University Press 1974

References

REFERENCES

Alford, R. H., Rossen, D. R., Butler, W. T. & Kasel, J. A. (1967). Neutralizing and haemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus. Journal of Immunology 98, 724.CrossRefGoogle Scholar
Cate, T. R., Rosen, R. D., Douglas, R. G., Butler, W. T. & Couch, R. B. (1966). The role of nasal secretion and serum antibody in the rhinoviras common cold. American Journal of Epidemiology 84, 352.CrossRefGoogle ScholarPubMed
Chanock, R. M., Kapikian, A. Z., Mills, J., Kim, H. W. & Parrott, R. M. (1970). Influence of immunological factors in respiratory syncytial virus disease of the lower respiratory tract. Archives of Environmental Health 21, 347.CrossRefGoogle Scholar
Chanock, R. M., Kim, H. W., Vargosko, A. J., Deleva, A., Johnson, K. M., Cumming, C. & Parrott, R. H. (1961). Respiratory syncytial virus. 1. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia and minor respiratory diseases in children. Journal of the American Medical Association 176, 647.Google Scholar
Coates, H. W., Alling, D. W. & Chanock, R. M. (1966). An antigenic analysis of respiratory syncytial virus isolation by a plaque reduction neutralization test. American Journal of Epidemiology 83, 299.CrossRefGoogle ScholarPubMed
Cohen, A. B., Goldberg, S. & London, R. L. (1970). Immunoglobulins in nasal secretions of infants. Clinical and Experimental Immunology 6, 753.Google ScholarPubMed
Fireman, P., Vannier, W. E. & Goodman, H. C. (1963). The association of skin-sensitizing antibody with the B2 A globulins in sera from ragweed-sensitive patients. Journal of Experimental Medicine 117, 603.CrossRefGoogle Scholar
Gardner, P. S., (1968). Virus infections and respiratory disease of childhood. Archives of Disease in Childhood 43, 629.CrossRefGoogle ScholarPubMed
Gardner, P. S., McQuillin, J. & Court, S. D. M. (1970). Speculation on pathogenesis in death from respirator syncytial virus infection. British Medical Journal i, 327.CrossRefGoogle Scholar
Gardner, P. S., McQuillin, J. & Scott, R. (1973). The role of local antibody in respiratory syncytial virus infections. Airborne transmission and airborne infection Fourth International Symposium on Aerobiology.Holland. P. 282. Utrecht, Oosthoek Publishing Co.Google Scholar
Gardner, P. S., Stanfield, J. P., Wright, A. E., Court, S. D. M. & Green, C. A. (1960). Viruses, bacteria and respiratory disease in children. British Medical Journal i, 1077.CrossRefGoogle Scholar
Gell, P. G. H. & Coombs, R. R. A. (1968). Clinical Aspects of Immunology, 2nd ed.Oxford: Blackwell Scientific Press.Google Scholar
Haworth, J. C. & Dilling, L. (1966). Concentration of γA-globulin in serum, saliva and nasopharyngeal secretions of infants and children. Journal of Laboratory and Clinical Medicine 67, 922.Google Scholar
Kapikian, A. Z., Mitchell, R. H., Chanock, R. M., Shvedoff, R. A. & Stewart, C. E. (1969). Respiratory syncytial virus infection in R.S. vaccinated children. American Journal of Epidemiology 89, 405.CrossRefGoogle Scholar
Kim, H. W., Arrobio, J. O., Pyles, G., Brandt, C. D., Carmargo, E., Chanock, R. M. & Parrott, R. H. (1971). Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Pediatrics 48, 745.CrossRefGoogle ScholarPubMed
Kim, H. W., Canchola, J. G., Brandt, D. C., Pyles, G., Chanock, R. M., Jensen, K. & Parrott, R. H. (1969a). Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89, 422.CrossRefGoogle ScholarPubMed
Kim, H. W., Bellanti, J. A., Arrobio, J. O., Mills, J., Brandt, C. D., Chanock, R. M. & Parrott, R. H. (1969b). Respiratory syncytial virus neutralising activity in nasal secretions following natural infection. Proceedings of the Society for Experimental Biology and Medicine 131, 658.CrossRefGoogle ScholarPubMed
Lowry, E. H., Rosebrough, N. J., Farr, A. & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265.CrossRefGoogle ScholarPubMed
Mancini, G., Carbonara, A. D. & Heremans, J. F. (1965). Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2, 235.CrossRefGoogle ScholarPubMed
Mills, J., Van Kirk, J. E., Wright, P. F. & Chanock, R. M. (1971). Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and and illness. Journal of Immunology 107, 123.CrossRefGoogle ScholarPubMed
Perkins, J. C., Tucker, D. N., Knopf, H. L. S., Wenzel, P., Kapikian, A. Z. & Chanock, R. M. (1969). Comparison of protective effect of neutralising antibody in serum and nasal secretions in experimental rhinovirus type 13 illness. American Journal of Epidemiology 90, 519.CrossRefGoogle ScholarPubMed
Remington, J. S., Vosti, K. L., Lietze, Q. & Zimmerman, A. L. (1964). Serum proteins and antibody activity in human nasal secretions. Journal of Clinical Investigation 43, 1613.CrossRefGoogle ScholarPubMed
Rossen, R. D., Schade, A. L., Butler, W. T. & Kasel, J. A. (1966). The proteins in nasal secretion: A longitudinal study of the γA-globulin, γG-globulin, albumin, siderophilin and total protein concentrations in nasal washings from adult male volunteers. Journal of Clinical Investigation 45, 768.CrossRefGoogle ScholarPubMed
Scott, R. & Gardner, P. S. (1970). Respiratory syncytial virus neutralizing activity in nasopharyngeal secretions. Journal of Hygiene 68, 581.Google ScholarPubMed
Smith, C. B., Purcell, R. H., Bellanti, J. A. & Chanock, R. M. (1966). Protective effect of antibody to parainfluenza type 1 virus. New England Journal of Medicine 275, 1145.CrossRefGoogle ScholarPubMed
Smith, D. B., Bellanti, J. A. & Chanock, R. M. (1967). Immunoglobulins in serum and nasal secretions following infection with type 1 parainfluenza virus and infection of inactivated vaccines. Journal of Immunology 99, 133.CrossRefGoogle ScholarPubMed
Sturdy, P. M., McQuillin, J. & Gardner, P. S. (1969). A comparative study of methods for the diagnosis of respiratory virus infections in childhood. Journal of Hygiene 67, 659.Google ScholarPubMed